Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteers Diabetes Mellitus, Type 2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01597713
What this trial is testing

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0362 in Healthy Subjects

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Healthy
Novo Nordisk A/S 83
Early research (Phase 1)Study completedNCT05248841
What this trial is testing

Demonstrate Pharmacokinetic and Pharmacodynamic Biosimilarity Between HEC-Glargine and US-Lantus® in Healthy Male Volunteers

Who this might be right for
Type 1 Diabetes MellitusType 2 Diabetes Mellitus
Lannett Company, Inc. 104
Large-scale testing (Phase 3)Study completedNCT00651105
What this trial is testing

Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects

Who this might be right for
Type-2 DiabetesHealthy
Novartis 63
Early research (Phase 1)Study completedNCT01474161
What this trial is testing

Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505

Who this might be right for
Type 2 DiabetesDiabetes Mellitus, Type 2Metabolic Diseases+3 more
Genfit 96
Early research (Phase 1)Study completedNCT00501683
What this trial is testing

A Single Dose Of GSK189075 Taken By Mouth Containing Small Amounts Of Radioactivity Studied In Healthy Male Volunteers

Who this might be right for
Type 2 Diabetes MellitusDiabetes Mellitus, Type 2
GlaxoSmithKline 8
Early research (Phase 1)Study completedNCT02022254
What this trial is testing

Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Healthy
Novo Nordisk A/S 24
Early research (Phase 1)Study completedNCT01571661
What this trial is testing

A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 16
Not applicableStudy completedNCT00529048
What this trial is testing

Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 Diabetes

Who this might be right for
Incretin Effect
Herlev Hospital 16
Early research (Phase 1)Study completedNCT06703658
What this trial is testing

Investigate Multiple Ascending Doses of AZD5004 in Healthy Japanese Participants and Participants With Type 2 Diabetes Mellitus

Who this might be right for
Healthy ParticipantsType 2 Diabetes
AstraZeneca 35
Early research (Phase 1)Study completedNCT07533539
What this trial is testing

Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of L03TD1 in Healthy Volunteers

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Celltrion 48
Early research (Phase 1)Study completedNCT04426708
What this trial is testing

A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers

Who this might be right for
Type 2 Diabetes Mellitus
Hua Medicine Limited 25
Early research (Phase 1)Study completedNCT07455825
What this trial is testing

Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 Years

Who this might be right for
Healthy Participants
AstraZeneca 65
Early research (Phase 1)Study completedNCT01028404
What this trial is testing

A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 84
Early research (Phase 1)Not Yet RecruitingNCT07518121
What this trial is testing

A Bridging Study of Efsubaglutide Alfa in Healthy Adults in Brazil

Who this might be right for
Diabete Type 2
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. 48
Early research (Phase 1)Study completedNCT00501930
What this trial is testing

Evaluate and Study Drug Levels in Blood Plasma When Giving High Doses of GSK189075 to Healthy Volunteers

Who this might be right for
Type 2 Diabetes MellitusDiabetes Mellitus, Type 2
GlaxoSmithKline 12
Testing effectiveness (Phase 2)Study completedNCT04143945
What this trial is testing

A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity

Who this might be right for
Healthy Volunteers Diabetes Mellitus, Type 2Healthy Volunteers OverweightHealthy Volunteers Obesity
Novo Nordisk A/S 104
Early research (Phase 1)Study completedNCT01358981
What this trial is testing

LY2881835 in Healthy People and People With Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 18
Early research (Phase 1)Study completedNCT07213895
What this trial is testing

Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Tablets Versus Trijardy® XR Extended Release Film Coated Tablets

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Humanis Saglık Anonim Sirketi 14
Early research (Phase 1)Study completedNCT01217905
What this trial is testing

Japanese Single and Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic (PK) & Pharmacodynamic (PD) Study of AZD7687

Who this might be right for
Type 2 DiabetesObesity
AstraZeneca 36
Early research (Phase 1)Study completedNCT03033433
What this trial is testing

DCB-DM101 in Healthy Volunteers and for Type 2 Diabetes Mellitus Patients

Who this might be right for
Type2 Diabetes
VitNovo, Inc. 28
Next Page